201 related articles for article (PubMed ID: 17582659)
21. Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation.
Debenham JS; Madsen-Duggan CB; Wang J; Tong X; Lao J; Fong TM; Schaeffer MT; Xiao JC; Huang CC; Shen CP; Sloan Stribling D; Shearman LP; Strack AM; Euan Macintyre D; Hale JJ; Walsh TF
Bioorg Med Chem Lett; 2009 May; 19(9):2591-4. PubMed ID: 19328684
[TBL] [Abstract][Full Text] [Related]
22. Design, syntheses, biological evaluation, and docking studies of 2-substituted 5-methylsulfonyl-1-phenyl-1H-indoles: potent and selective in vitro cyclooxygenase-2 inhibitors.
Cruz-López O; Díaz-Mochón JJ; Campos JM; Entrena A; Núñez MT; Labeaga L; Orjales A; Gallo MA; Espinosa A
ChemMedChem; 2007 Jan; 2(1):88-100. PubMed ID: 17131462
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, modelling, and antimitotic properties of tricyclic systems characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole moiety.
Pinna GA; Murineddu G; Murruzzu C; Zuco V; Zunino F; Cappelletti G; Artali R; Cignarella G; Solano L; Villa S
ChemMedChem; 2009 Jun; 4(6):998-1009. PubMed ID: 19291736
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives.
Bhandari SV; Bothara KG; Raut MK; Patil AA; Sarkate AP; Mokale VJ
Bioorg Med Chem; 2008 Feb; 16(4):1822-31. PubMed ID: 18248993
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological property of some novel 1,3,4-oxadiazoles.
Ramaprasad GC; Kalluraya B; Kumar BS; Hunnur RK
Eur J Med Chem; 2010 Oct; 45(10):4587-93. PubMed ID: 20708305
[TBL] [Abstract][Full Text] [Related]
26. Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists.
Kiyoi T; Adam JM; Clark JK; Davies K; Easson AM; Edwards D; Feilden H; Fields R; Francis S; Jeremiah F; McArthur D; Morrison AJ; Prosser A; Ratcliffe PD; Schulz J; Wishart G; Baker J; Campbell R; Cottney JE; Deehan M; Epemolu O; Evans L
Bioorg Med Chem Lett; 2011 Mar; 21(6):1748-53. PubMed ID: 21316962
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid.
Gilani SJ; Khan SA; Siddiqui N
Bioorg Med Chem Lett; 2010 Aug; 20(16):4762-5. PubMed ID: 20643545
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a novel class of selective human CB1 inverse agonists.
Foloppe N; Allen NH; Bentley CH; Brooks TD; Kennett G; Knight AR; Leonardi S; Misra A; Monck NJ; Sellwood DM
Bioorg Med Chem Lett; 2008 Feb; 18(3):1199-206. PubMed ID: 18083560
[TBL] [Abstract][Full Text] [Related]
29. Optimisation of a novel series of selective CNS penetrant CB(2) agonists.
Watson C; Owen DR; Harding D; Kon-I K; Lewis ML; Mason HJ; Matsumizu M; Mukaiyama T; Rodriguez-Lens M; Shima A; Takeuchi M; Tran I; Young T
Bioorg Med Chem Lett; 2011 Jul; 21(14):4284-7. PubMed ID: 21669533
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of novel alkenylthiophenes as potent and selective CB1 cannabinoid receptor antagonists.
Tai CL; Hung MS; Pawar VD; Tseng SL; Song JS; Hsieh WP; Chiu HH; Wu HC; Hsieh MT; Kuo CW; Hsieh CC; Tsao JP; Chao YS; Shia KS
Org Biomol Chem; 2008 Feb; 6(3):447-50. PubMed ID: 18219411
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of 3,5-disubstituted-1,2,4-oxadiazoles as potent inhibitors of phosphodiesterase4b2.
Kumar D; Patel G; Vijayakrishnan L; Dastidar SG; Ray A
Chem Biol Drug Des; 2012 May; 79(5):810-8. PubMed ID: 22176507
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological activity of oxadiazole and triazolothiadiazole derivatives as tyrosinase inhibitors.
Lam KW; Syahida A; Ul-Haq Z; Abdul Rahman MB; Lajis NH
Bioorg Med Chem Lett; 2010 Jun; 20(12):3755-9. PubMed ID: 20493688
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate.
Ratcliffe P; Adam JM; Baker J; Bursi R; Campbell R; Clark JK; Cottney JE; Deehan M; Easson AM; Ecker D; Edwards D; Epemolu O; Evans L; Fields R; Francis S; Harradine P; Jeremiah F; Kiyoi T; McArthur D; Morrison A; Passier P; Pick J; Schnabel PG; Schulz J; Steinbrede H; Walker G; Westwood P; Wishart G; Udo de Haes J
Bioorg Med Chem Lett; 2011 Apr; 21(8):2541-6. PubMed ID: 21411321
[TBL] [Abstract][Full Text] [Related]
34. Novel sterically hindered cannabinoid CB1 receptor ligands.
Urbani P; Cascio MG; Ramunno A; Bisogno T; Saturnino C; Di Marzo V
Bioorg Med Chem; 2008 Aug; 16(15):7510-5. PubMed ID: 18579386
[TBL] [Abstract][Full Text] [Related]
35. Novel benzimidazole derivatives as selective CB2 agonists.
Pagé D; Balaux E; Boisvert L; Liu Z; Milburn C; Tremblay M; Wei Z; Woo S; Luo X; Cheng YX; Yang H; Srivastava S; Zhou F; Brown W; Tomaszewski M; Walpole C; Hodzic L; St-Onge S; Godbout C; Salois D; Payza K
Bioorg Med Chem Lett; 2008 Jul; 18(13):3695-700. PubMed ID: 18522867
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, analgesic and anti-inflammatory activities of novel 3-(4-acetamido-benzyl)-5-substituted-1,2,4-oxadiazoles.
Farooqui M; Bora R; Patil CR
Eur J Med Chem; 2009 Feb; 44(2):794-9. PubMed ID: 18621449
[TBL] [Abstract][Full Text] [Related]
37. Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: identification of a lead and initial SAR studies.
Lambeng N; Lebon F; Christophe B; Burton M; De Ryck M; Quéré L
Bioorg Med Chem Lett; 2007 Jan; 17(1):272-7. PubMed ID: 17027269
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.
Diaz P; Xu J; Astruc-Diaz F; Pan HM; Brown DL; Naguib M
J Med Chem; 2008 Aug; 51(16):4932-47. PubMed ID: 18666769
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists.
Moir EM; Yoshiizumi K; Cairns J; Cowley P; Ferguson M; Jeremiah F; Kiyoi T; Morphy R; Tierney J; Wishart G; York M; Baker J; Cottney JE; Houghton AK; McPhail P; Osprey A; Walker G; Adam JM
Bioorg Med Chem Lett; 2010 Dec; 20(24):7327-30. PubMed ID: 21074434
[TBL] [Abstract][Full Text] [Related]
40. Studies of cannabinoid-1 receptor antagonists for the treatment of obesity: hologram QSAR model for biarylpyrazolyl oxadiazole ligands.
Ye M; Dawson MI
Bioorg Med Chem Lett; 2009 Jun; 19(12):3310-5. PubMed ID: 19427207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
